Online citations, reference lists, and bibliographies.
← Back to Search

Jumping On The Bandwagon: A Review On The Versatile Applications Of Gold Nanostructures In Prostate Cancer

Monira Sarkis, Esther Ghanem, Kamil Rahme
Published 2019 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Prostate cancer (PCa) has remarkably emerged as a prominent disease in the face of the male population. Conventional treatments like prostatectomy or radiation can be curative only if PCa is diagnosed at an early stage. In the field of targeted therapy, a bevy of novel therapeutic approaches have left a landmark in PCa treatment and have proven to extend survival via distinct modes of actions. Nanotherapy has started to take root and has become the hype of the century by virtue of its abundant advantages. Scientists have invested a great deal of interest in the development of nanostructures such as gold nanoparticles (AuNPs), which hold particularly great hope for PCa theranostics. In this article, we present an overview of the studies published after 1998 that involve the use of different functionalized AuNPs to treat and diagnose PCa. Special reference is given to various in vitro and in vivo methods employed to shuttle AuNPs to PCa cells. Major studies show an enhancement of either detection or treatment of PCa when compared to their non-targeted counterparts, especially when AuNPs are tagged with specific ligands, such as antibodies, tea natural extracts, folate, anisamide, receptor inhibitors, and chitosan. Future approaches of treatment are dependent on those worthy multifunctional molecules, and are dictated by their ability to achieve a more versatile cancer therapeutic approach.
This paper references
10.1155/2018/5837276
Gold Nanoparticles as X-Ray, CT, and Multimodal Imaging Contrast Agents: Formulation, Targeting, and Methodology
Matthew M. Mahan (2018)
10.1016/j.tips.2009.08.004
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Y. Malam (2009)
10.1021/acs.nanolett.7b04209
Targetable Clinical Nanoparticles for Precision Cancer Therapy Based on Disease-Specific Molecular Inflection Points.
C. Kaittanis (2017)
10.3892/ijo.2017.4095
Gold-chrysophanol nanoparticles suppress human prostate cancer progression through inactivating AKT expression and inducing apoptosis and ROS generation in vitro and in vivo
L. Lu (2017)
10.1039/c7dt00383h
Mangiferin functionalized radioactive gold nanoparticles (MGF-198AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy.
A. Y. Al-Yasiri (2017)
10.1002/adhm.201501035
Cancer Cell Internalization of Gold Nanostars Impacts Their Photothermal Efficiency In Vitro and In Vivo: Toward a Plasmonic Thermal Fingerprint in Tumoral Environment.
A. Espinosa (2016)
10.1007/S12030-008-9003-3
Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells
J. Lu (2007)
10.1002/anie.200904359
Gold nanoparticles for biology and medicine.
D. Giljohann (2010)
10.1016/J.SNB.2018.03.179
Gold nanoparticle triggered dual optoplasmonic-impedimetric sensing of prostate-specific antigen on interdigitated porous silicon platforms
Chloé Rodriguez (2018)
10.1517/17425247.2014.891582
Gold nanoparticle conjugates: recent advances toward clinical applications
Roberto Cao-Milán (2014)
10.1016/j.jcis.2017.09.079
Electrochemical immunoassay for detection of prostate specific antigen based on peptide nanotube-gold nanoparticle-polyaniline immobilized pencil graphite electrode.
Tayfun Vural (2018)
10.1116/1.2815690
Nanomaterials and nanoparticles: Sources and toxicity
C. Buzea (2007)
10.1039/B514191E
Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes.
S. Eustis (2006)
10.1002/smll.201001459
In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
Q. He (2011)
10.1016/j.jconrel.2015.10.036
Comparative effect of gold nanorods and nanocages for prostate tumor hyperthermia.
R. Robinson (2015)
10.1016/j.nano.2012.05.009
Nanoparticle therapeutics for prostate cancer treatment.
V. Sanna (2012)
10.1039/c1nr11188d
Gold nanoparticles: preparation, properties, and applications in bionanotechnology.
Yi-Cheun Yeh (2012)
A Brief Review on the Application of Gold Nanoparticles as Sensors in Multi Dimensional Aspects
B. Paul (2015)
10.1002/ADMA.200701962
Testing Nanomaterials of Unknown Toxicity: An Example Based on Platinum Nanoparticles of Different Shapes
A. Elder (2007)
10.1016/j.ijpharm.2016.05.027
Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Jianfeng Guo (2016)
10.1007/s10534-013-9645-z
Antimicrobial silver: uses, toxicity and potential for resistance
K. Mijnendonckx (2013)
10.1016/j.drudis.2012.03.010
Theranostic applications of nanoparticles in cancer.
Naveed Ahmed (2012)
10.1038/nprot.2017.031
Cancer imaging using surface-enhanced resonance Raman scattering nanoparticles
Stefan Harmsen (2017)
10.1038/s41598-018-19733-z
A comparative Study of Aptasensor Vs Immunosensor for Label-Free PSA Cancer Detection on GQDs-AuNRs Modified Screen-Printed Electrodes
M. Srivastava (2018)
10.1002/PON.572
Prostate cancer and health‐related quality of life: a review of the literature
D. Eton (2002)
10.1021/acsnano.8b00940
Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
J. Mangadlao (2018)
10.1016/B978-0-08-101022-8.00013-2
Electrospun-based systems in cancer therapy
Mohammad Norouzi (2017)
10.1038/s41598-017-03015-1
Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice
L. Yang (2017)
10.2217/nnm-2016-0062
Preclinical evaluation of gold-DTDTPA nanoparticles as theranostic agents in prostate cancer radiotherapy.
K. Butterworth (2016)
10.1021/ja104924b
Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy.
W. Lu (2010)
10.1016/j.enzmictec.2017.10.009
Development of an electrochemical immunosensor based on gold nanoparticles incorporated chitosan biopolymer nanocomposite film for the detection of prostate cancer using PSA as biomarker.
L. Suresh (2018)
10.1089/cbr.2014.1660
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide.
Catharina M van Rij (2014)
10.1016/j.fct.2014.12.019
Silver nanoparticles: their potential toxic effects after oral exposure and underlying mechanisms--a review.
S. Gaillet (2015)
10.1016/j.bmcl.2012.11.015
Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.
Benjamin B. Kasten (2013)
10.1007/978-3-642-00477-3_2
Nanoparticle technologies for cancer therapy.
F. Alexis (2010)
10.1007/BF02564756
Prostate gland: Structure, functions and regulation
V. Kumar (2007)
Solid lipid nanoparticles for parenteral drug
S. A. Wissing (2004)
10.1053/HP.2000.6698
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.
L. Bubendorf (2000)
Beitrage zur Optik triiber Medien
G. Mie (1908)
10.1038/s41598-017-11680-5
A signal-on built in-marker electrochemical aptasensor for human prostate-specific antigen based on a hairbrush-like gold nanostructure
N. Sattarahmady (2017)
10.7150/thno.22435
Engineered Zn(II)-Dipicolylamine-Gold Nanorod Provides Effective Prostate Cancer Treatment by Combining siRNA Delivery and Photothermal Therapy
Kyung Hyun Min (2017)
10.1038/s41598-017-13736-y
Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization
E. Lechtman (2017)
10.1038/mtna.2014.32
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Hongguang Sun (2014)
10.1063/1.2777127
Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging
A. Agarwal (2007)
10.1002/tox.22526
Genotoxicity, biochemical, and biodistribution studies of magnesium oxide nano and microparticles in albino wistar rats after 28‐day repeated oral exposure
Bhanuramya Mangalampalli (2018)
10.1016/j.nano.2009.07.003
Toxicity issues in the application of carbon nanotubes to biological systems.
Constantine P Firme (2010)
10.1021/AR960016N
Some interesting properties of metals confined in time and nanometer space of different shapes.
M. El-Sayed (2001)
10.3109/17435390903569639
A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics
H. Johnston (2010)
10.1038/srep40003
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries
S. Chen (2017)
10.3109/02656736.2010.485593
Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy
S. Krishnan (2010)
10.1007/S11468-007-9031-1
Review of Some Interesting Surface Plasmon Resonance-enhanced Properties of Noble Metal Nanoparticles and Their Applications to Biosystems
P. Jain (2007)
10.2147/NSA.S8984
Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules.
R. Delong (2010)
10.2147/IJN.S2810
EphrinA1-targeted nanoshells for photothermal ablation of prostate cancer cells
Andre M. Gobin (2008)
10.1006/PHRS.2000.0695
Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
A. Fundaró (2000)
10.1021/BC0499127
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.
A. Patri (2004)
10.1007/978-3-319-41129-3_2
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
10.1021/acs.bioconjchem.6b00568
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor.
S. Avvakumova (2016)
10.1089/CBR.2014.1660
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2×Anti-HSG Bispecific Antibody and a (177)Lu-Labeled Peptide.
M van RijCatharina (2014)
10.1038/nrc2351
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
H. Lilja (2008)
10.4314/TJPR.V13I7.23
Gold Nanoparticles: Synthesis and Applications in Drug Delivery
A. Khan (2014)
10.1148/RADIOLOGY.187.2.8475269
Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study.
C. Nolsøe (1993)
10.1038/s41598-017-11292-z
Selective uptake of epidermal growth factor-conjugated gold nanoparticle (EGF-GNP) facilitates non-thermal plasma (NTP)-mediated cell death
Wanil Kim (2017)
10.1021/acsami.5b00371
Gold nanoparticle-enabled blood test for early stage cancer detection and risk assessment.
T. Zheng (2015)
10.3109/10408440903453074
A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity
H. Johnston (2010)
10.2217/nnm.11.79
In vivo biodistribution of nanoparticles.
Joao Paulo Mattos Almeida (2011)
10.1007/s11596-018-1989-8
Biodistribution and Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles In Vitro and In Vivo
Q. Yu (2018)
10.1039/C4TB00643G
Ultra-effective photothermal therapy for prostate cancer cells using dual aptamer-modified gold nanostars.
Hunho Jo (2014)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1016/J.JURO.2007.09.018
Selective prostate cancer thermal ablation with laser activated gold nanoshells.
J. Stern (2008)
10.1021/ac8004555
Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy.
K. Male (2008)
10.1007/s12668-016-0390-y
Towards One-Step Quantitation of Prostate-Specific Antigen (PSA) in Microfluidic Devices: Feasibility of Optical Detection with Nanoparticle Labels
A. I. Barbosa (2017)
10.1016/j.ejca.2013.02.026
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.
P. Gannon (2013)
Guidelines on Prostate Cancer; European Association of Urology: Arnhemthe
N. Mottet (2015)
10.1016/j.copbio.2013.02.020
Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
L. Rizzo (2013)
10.2217/nnm-2016-0318
Dual plasmonic gold nanostars for photoacoustic imaging and photothermal therapy.
Vijay Raghavan (2017)
Guidelines on Prostate Cancer
A. Heidenreich (2013)
10.2217/nnm.15.183
EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment.
Li-Chu Tsai (2016)
10.1002/tox.21908
Assessment of pulmonary toxicity of MgO nanoparticles in rats
Kiranmai Gelli (2015)
10.1073/pnas.1121174109
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer
R. Shukla (2012)
10.1039/c2cc32313c
A gold nanocage-CNT hybrid for targeted imaging and photothermal destruction of cancer cells.
Sadia Afrin Khan (2012)
10.3332/ecancer.2012.ed16
The difficulties in cancer treatment
S. Chakraborty (2012)
10.7150/thno.14988
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
L. Zou (2016)
10.1021/JP057170O
Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine.
P. Jain (2006)
10.3390/ijms18051102
Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications—Focus on Prostate and Breast Cancer
J. Elgqvist (2017)
10.1016/j.ab.2017.08.001
Graphene oxide layer decorated gold nanoparticles based immunosensor for the detection of prostate cancer risk factor.
Mintu Pal (2017)
10.1039/C6TB00082G
Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer - synthesis, physicochemical characterisation and in vitro evaluation.
K. A. Fitzgerald (2016)
Detection of prostate cancer risk factor immunosensor based deposition of graphene layer decorated gold nanoparticles
M. Pal (2017)
10.1016/j.biomaterials.2012.12.043
The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes.
Changhui Fu (2013)
10.1016/j.drudis.2017.04.018
Magnetic nanoformulations for prostate cancer.
P. Chowdhury (2017)
10.1177/1091581815600170
Initial Evaluation of the Safety of Nanoshell-Directed Photothermal Therapy in the Treatment of Prostate Disease
J. Stern (2016)
10.1016/j.biomaterials.2012.04.045
ROS-mediated apoptotic cell death in prostate cancer LNCaP cells induced by biosurfactant stabilized CdS quantum dots.
B. Singh (2012)
10.1016/j.pharep.2014.10.019
The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies.
M. Bednarski (2015)
10.1177/2211068216669710
Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)–Targeted Photothermal Therapy
Kristine M. Mayle (2017)
10.1021/acsami.5b07029
Genetically Programmed Clusters of Gold Nanoparticles for Cancer Cell-Targeted Photothermal Therapy.
M. H. Oh (2015)
10.2174/1872210511666171101120157
An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer.
Selvarathinam Thambiraj (2018)
10.3390/molecules22050857
Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines †
S. A. C. Carabineiro (2017)
10.1007/s11307-008-0185-9
Biodistributions of 177Lu- and 111In-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of 111In-7E11 as a Pre-therapeutic Agent for 177Lu-7E11 Radioimmunotherapy
Mei-Hsiu Pan (2008)
10.1007/978-3-319-22942-3_6
Gold-Based Nanomaterials for Applications in Nanomedicine.
Sumaira Ashraf (2016)
10.1136/BMJ.309.6962.1099
The future of medicine
I. Morrison (1994)
10.32607/20758251-2011-3-2-34-56
Gold Nanoparticles in Biology and Medicine: Recent Advances and Prospects
L. A. Dykman (2011)
10.1021/mp800051m
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
10.2478/intox-2013-0012
Acute toxicity of 31 different nanoparticles to zebrafish (Danio rerio) tested in adulthood and in early life stages – comparative study
J. Kovrižnych (2013)
10.1073/pnas.1714587115
PSMA-targeted polyinosine/polycytosine vector induces prostate tumor regression and invokes an antitumor immune response in mice
Y. Langut (2017)
10.3390/nano8060410
Biodistribution and Toxicity of Micellar Platinum Nanoparticles in Mice via Intravenous Administration
Anna L. Brown (2018)
10.4103/0974-2077.63301
Nanotechnology: The Future Medicine
R. Saini (2010)
10.1016/J.MSER.2013.03.001
Nanoparticles for Improving Cancer Diagnosis.
H. Chen (2013)
10.1016/J.BIOS.2004.11.016
Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assays.
Lieven Huang (2005)
10.1593/NEO.04112
Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.
S. Shukla (2004)
10.1038/s41598-017-18304-y
Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles
A. Khoo (2017)
10.1002/ANDP.19083300302
Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen
G. Mie (1908)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar